Epinephrine

규격

51-43-4CAS 번호

200-098-7EC 번호

4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diolIUPAC 명칭

C9H13NO3화학식

183.2 g/mol분자량

epinephrine; adrenaline; l-Adrenaline; Adrenalin; Levoepinephrine; Epinefrina; Nephridine; Adnephrine; Chelafrin; Epinephran; Epipen; Epirenan; (-)-Adrenaline; Renoform; (R)-Adrenaline; Hypernephrin; Renostypticin; Adrenine; Hemisine; Hemostasin; Levorenin; Levorenine; Mucidrina; Nieraline; Paranephrin; Renaglandin; Renaleptine; Renalina; Bosmin; Exadrin; Adrin; Vasoconstrictine; Bronkaid Mist; Primatene Mist; Methylarterenol; Adrenalinum; Glauposine; Hemostatin; Scurenaline; Styptirenal; Supracapsulin; Supranephrane; Vasotonin; Simplene; Takamina; Twinject; (-)-(R)-Epinephrine; Antiasthmatique; Esphygmogenina; Isoptoepinal; Sphygmogenin; Stryptirenal; Supranephrine; (R)-Epinephrine; Adrenamine; Adrenapax; Adrenasol; Adrenodis; Adrenohorma; Adrenosan; Adrenutol; Astmahalin; Astminhal; Balmadren; Bernarenin; Biorenine; Brevirenin; Drenamist; Dylephrin; Glaucosan; Glycirenan; Haemostasin; Haemostatin; Hektalin; Hyporenin; Intranefrin; Kidoline; Myosthenine; Sindrenina; Soladren; Supranefran; Supranol; Takamine; Tokamina; Vasodrine; Corisol; Mytrate; Suprel; Asthma-nefrin; Asmatane Mist; Sympathin I; Asthma meter mist; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; Adrenalin-Medihaler; Dyspne-Inhal; R-(-)-Epinephrine; Epinephrinum; Epinefrin; Susphrine; 1-Epinephrine; 1-Adrenalin; Epipen Jr.; Renaglandulin; Renostypricin; Vasoconstrictor; Adrenalina; Adrenatrate; Epirenin; Metanephrin; Renagladin; Surenine; (R)-(-)-Adrenaline; Vasoton; Rcra waste number P042; R-Adrenaline; Auvi-q; Methylaminoethanolcatechol; (R)-(-)-Epinephrine; Adrenaclick; Epinefrina [INN-Spanish]; Epinephrinum [INN-Latin]; Adrenan; Epinephrin; Lyodrin; Symjepi; Adrine; (R)-(-)-Adnephrine; EPIPEN E Z PEN; (R)-(-)-Epirenamine; EPI E Z PEN JR; Twinject 0.3; Auvi-Q auto-injector; Twinject 0.15; Racepinefrine, (r)-; EPIPEN JR; Levoreninum; CCRIS 4812; Anapen; DTXSID5022986; HSDB 4289; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; AI3-19015; UNII-YKH834O4BH; EINECS 200-098-7; NSC 62786; 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; 1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-; NSC-62786; (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; DTXCID802986; 1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-; Epinephrine [USP:INN:BAN:JAN]; OCTOCAINE COMPONENT EPINEPHRINE; IONTOCAINE COMPONENT EPINEPHRINE; 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol; 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-; Epinefrina (INN-Spanish); Epinephrinum (INN-Latin); ADRENALINE (MART.); ADRENALINE [MART.]; EPINEPHRINE (USP-RS); EPINEPHRINE [USP-RS]; ADRENALINE (EP IMPURITY); ADRENALINE [EP IMPURITY]; LIDOSITE TOPICAL SYSTEM KIT COMPONENT EPINEPHRINE; ADRENALINE (EP MONOGRAPH); ADRENALINE [EP MONOGRAPH]; Epinephrine (USP:INN:BAN:JAN); EPINEPHRINE (USP MONOGRAPH); EPINEPHRINE [USP MONOGRAPH]; 4-((1R)-1-HYDROXY-2-(METHYLAMINO)ETHYL)-1,2-BENZENEDIOL; epineprine; (R)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol; 4-((1R)-1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol; adrAnaline; EpinJect; Epinephrine1553; epinephrine solution; Prime Asthma Relief; ASTHMAHALIN; Epinephrine Inhalation; RefChem:6426; ADRENALIN(R); epinephrine|racepinefrine; ADRENALIN (EPINEPHRINE); A01AD01; B02BC09; C01CA24; EPINEPHRINE (AUTOINJECTOR); R01AA14; R03AA01; S01EA01; Episnap Epinephrine Convenience Kit; EPINEPHRINE COMPONENT OF OCTOCAINE; EPINEPHRINE COMPONENT OF IONTOCAINE; V49663C-25 SPINAL 25G PENCIL POINT NOVAPLUS; EPINEPHRINE COMPONENT OF LIDOSITE TOPICAL SYSTEM KIT; 3,4-DIHYDROXY-1-(1-HYDROXY-2-(METHYLAMINO)ETHYL)BENZENE; 200-098-7; 4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol; 51-43-4; L-epinephrine; (-)-Epinephrine; Adrenal; Sus-Phrine; Epifrin; Tonogen; l-Epirenamine; Lyophrin; Supradin; Epiglaufrin; Renostyptin; Levorenen; Eppy; Epinefrin [Czech]; Surrenine; d-Adrenaline; l-Epinephrine (synthetic); Adrenalina [DCIT]; l-Adrenalin; l-Methylaminoethanolcatechol; SUS-PHRINE SULFITE-FREE; L-Epinehphrine; l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; RCRA waste no. P042; Micronefrin; NEFFY; (-)-R-Epinephrine; Sus-phrine sulphite-free; Lopac-E-4642; 1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]-; CHEMBL679; YKH834O4BH; Levo-Methylaminoethanolcatechol; D-Epinephrine; D-Epifrin; CHEBI:28918; Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-; (-)-Adrenalin; (r)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol; NCGC00015417-01; NCGC00142615-03; NCGC00142615-08; 1,2-Benzenediol, 4-((1R)-1-hydroxy-2-(methylamino)ethyl)-; (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol; (R)-4-[1-Hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; Exadri; (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol; l-Epinephine; Asthmahaler Mist; Ana-Guard; Ana-Kit; CAS-51-43-4; Epipen EZ Pen; L-Adrenaline Base; Epi EZ Pen Jr; ADROP; Epinephrine [USAN:INN:JAN]; Epipen Auto-Injector; Bronkaid Suspension Mist; RACEPINEFRINE HYDROCHLORIDE, (R)-; Epipen Jr. Auto-Injector; NSC62786; Bupivacaine Hcl and Epinephrine; MFCD00063027; Adrenaline CRS; Benzyl alcohol, 3,4-dihydroxy-.alpha.-[(methylamino)methyl]-, (-)-; BENZYL ALCOHOL, 3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)-, (-)-; Adrenalin (TN); ALE; IOP; Epinephrine (USP); Epipen (TN); nchembio747-comp9; Twinject 0.30; Adrenaline/Epinephrine; (-)-Epinephrine;L-Adrenaline;(-)-Adrenalin; Adrenaline (JP15); Adrenaline (JP18); Epitrate (Salt/Mix); Auvi-q (TN); ADRENALINE [JAN]; Epinephrine (USP/INN); EPINEPHRINE [MI]; EPINEPHRINE [INN]; Adrenaline impurity F CRS; ADRENALINUM [HPUS]; EPINEPHRINE [HSDB]; bmse000316; Epitope ID:768757; 4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol #; Citanest Forte (Salt/Mix); L-Adrenaline (Epinephrine); SCHEMBL3814; 3,4-Dihydroxy-.alpha.-((methylamino)methyl)benzyl alcohol; EPINEPHRINE [WHO-DD]; EPINEPHRINE [WHO-IP]; GTPL479; BIDD:GT0119; E4250_SIGMA; orb3025406; (-)-Epinephrine (+)-bitartrate salt;L-Adrenaline (+)-bitartrate salt; SCHEMBL29353423; BDBM44818; cid_6852374; HY-B0447B; component of E-Pilo (Salt/Mix); EPINEPHRINE [ORANGE BOOK]; GLXC-14445; HMS3884H06; 104655-05-2; EPINEPHRINUM [WHO-IP LATIN]; Tox21_111562; BDBM50029050; EBC-12200; HSCI1_000215; PDSP1_001120; PDSP2_001104; s2522; SBB012384; 51-43-4 (FREE BASE); AKOS024283500; Tox21_111562_1; CCG-204593; DB00668; FA10705; MSK000565-100M; SDCCGSBI-0050486.P002; SMP1_000227; (-)-Epinephrine, >=97.0% (NT); NCGC00142615-01; NCGC00142615-04; NCGC00142615-05; NCGC00142615-06; NCGC00142615-07; NCGC00142615-09; NCGC00142615-18; NCGC00142615-21; AC-13188; AC-31211; AS-13813; DA-50242; ST069368; 4,5-beta-trihydroxy-N-methylphenethylamine; A0173; E6432; NS00010349; SW219274-1; C00788; D00095; D88222; EN300-120880; AB00573227-11; AB00573227-12; AB00573227-13; AB00573227_14; AB00573227_15; (-)-Epinephrine Solution in Methanol, 100ug/mL; Q132621; 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol; ethanol, 1-(3,4-dihydroxyphenyl)-2-(methylamino)-; SR-01000075267-8; Adrenaline; Noradrenaline EP Impurity A; Epinephrine; BRD-K63126190-001-03-6; BRD-K63126190-001-04-4; BRD-K63126190-001-05-1; BRD-K63126190-003-01-6; BRD-K63126190-046-02-3; BRD-K63126190-046-03-1; NORADRENALINE TARTRATE IMPURITY A [EP IMPURITY]; 4-[(1R)-1-hydroxy-2-methylaminoethyl]benzene-1,2-diol; Z1255449978; (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol; Adrenaline, European Pharmacopoeia (EP) Reference Standard; (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]pyrocatechol;tartaric acid; Adrenaline with impurity F, European Pharmacopoeia (EP) Reference Standard; 2,3-bis(oxidanyl)butanedioic acid;4-[(1R)-2-(methylamino)-1-oxidanyl-ethyl]benzene-1,2-diol동의어